Meag Munich Ergo’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-408,987
Closed -$32.8M 206
2025
Q1
$32.8M Buy
408,987
+5,323
+1% +$443K 0.96% 50
2024
Q4
$32.9M Sell
403,664
-180,458
-31% -$15M 1.04% 49
2024
Q3
$48.2M Sell
584,122
-117,877
-17% -$8.81M 1.51% 28
2024
Q2
$49.3M Sell
701,999
-69,424
-9% -$4.96M 1.64% 22
2024
Q1
$57.2M Buy
771,423
+29,121
+4% +$2.03M 2.07% 12
2023
Q4
$49.1M Buy
742,302
+86,091
+13% +$5.39M 1.86% 16
2023
Q3
$41.3M Buy
656,211
+8,784
+1% +$547K 1.8% 15
2023
Q2
$36.6M Buy
647,427
+52,178
+9% +$2.9M 1.59% 24
2023
Q1
$34.5M Sell
595,249
-5,470
-0.9% -$369K 1.63% 24
2022
Q4
$43.5M Buy
600,719
+61,120
+11% +$4.38M 2.34% 13
2022
Q3
$32.8M Sell
539,599
-154,499
-22% -$9.87M 1.99% 22
2022
Q2
$43.6M Buy
694,098
+102,739
+17% +$6.8M 2.6% 9
2022
Q1
$42.1M Sell
591,359
-3,211
-0.5% -$217K 3.04% 2
2021
Q4
$37.3M Buy
+594,570
New +$37.3M 2.65% 9

Other funds holding MET

Meag Munich Ergo's MET Position: Q2 2025 in Review

Meag Munich Ergo sold out of MetLife (MET) in Q2 2025, closing a stake of 408,987 shares — an estimated $32.8M sold.

Meag Munich Ergo first reported a position in MET in Q4 2021 and held it in 14 quarters. The position peaked at $57.2M in Q1 2024. 1,410 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Meag Munich Ergo reported no remaining MetLife position as of Q2 2025 after selling out during the quarter.
  • Meag Munich Ergo sold 408,987 MetLife shares in Q2 2025, an estimated $32.8M.
  • Meag Munich Ergo first reported a position in MetLife in Q4 2021 and held it in 14 quarters.
  • Meag Munich Ergo's MetLife position peaked at $57.2M in Q1 2024.
  • 1,410 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.